Financial News

Teva Pharm to pay Oklahoma US$85 million to settle opioid claims

Oklahoma has reached a US$85 million settlement agreement with Israeli-based Teva Pharmaceutical Industries Ltd ahead of the start of a trial in a multibillion-dollar lawsuit over the opioid epidemic, the state’s attorney general said on Sunday.

Exit mobile version
Skip to toolbar